2105 Study Part B
Participate in a clinical study of a potential new cancer treatment
This study has a tentative check-in date of February 2022.
This is a potential treatment for several cancers (including breast & ovarian cancer) that has already gone through clinical trials with patients. In this study we will compare how different formulations of the medication are metabolized. This investigational product inhibits specific proteins that play a role in the growth of cancer cells. It is not a form of chemo- or radiotherapy.
There is a 4 day & night consecutive stay in-house at our St. Paul facility plus 1 follow-up visit & 1 follow-up phone call
Reimbursement for study participation will be provided for time and travel of up to $1,750. This study has been approved by an independent ethics committee
Call Gigi at 651-724-7832 or register your interest to discuss your eligibility today!